Replies to post #688030 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

exwannabe,

😊. I think Advent is about ready to be able to treat 12,000 patients per year rather than nearly 4 year survivors… although treatment of lower grade gliomas and GBM/rGBM might lead to 12,000 patients per year as the new survival numbers get stretched out. At that point a push for a cure and not chronic treatment would be pressed for hard. Anyone working on that?; ). Best wishes.